Silicosis clinical trials
The registry lists 20 studies for Silicosis across more than 10 countries. 3 are recruiting or about to start. 16 of them are mainly about Silicosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-06.
Get an email when these change. Save the Silicosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Huashan Hospital (2) · Tel-Aviv Sourasky Medical Center (2) · The University of Queensland (2) · Wei Yu (1) · Chinese University of Hong Kong (1) · Samuel Hatfield (1) · Instituto de investigación e innovación biomédica de Cádiz (1) · Zhejiang University (1)
What is being tested here
Drugs under test in Silicosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Isoniazid | 0 | 1 | 1 |
| Pirfenidone | 0 | 0 | 1 |
| Nintedanib | 0 | 0 | 1 |
Who these studies take
Of the 1 Silicosis studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 1 (100%) for men only; 1 (100%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 0 (0%) | 1 (100%) |
| 30 | 0 (0%) | 1 (100%) |
| 40 | 0 (0%) | 1 (100%) |
| 50 | 0 (0%) | 1 (100%) |
| 65 | 0 (0%) | 1 (100%) |
| 75 | 0 (0%) | 1 (100%) |
| 85 | 0 (0%) | 1 (100%) |
Across all 20 studies, recruiting or not: 35% stop at 75 or younger and 25% at 65; 15% take children; 0% are for women only and 35% for men only; 30% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 20 of 20. search them.
- Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective StudyNot yet recruitingNCT069229161 country
- Silicosis and Silicotuberculosis Among Small Scale Gemstone Miners in Northern TanzaniaRecruitingNCT064038001 country
- Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in BrazilNot yet recruitingNCT06011785Early Phase 11 country
- KAP TB in Senior Management Officials of Companies With Increased Silica ExposureCompletedNCT077498721 country
- Reducing Silica Exposure Among Brick Kiln Workers in NepalCompletedNCT06090370Not applicable2 countries
- Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in OklahomaCompletedNCT042057081 country
- Silicosis Treatment, Action, Screening and Surveillance in Rwanda TrialsStatus unknownNCT055382991 country
- The SHIELD Study-silicosisStatus unknownNCT055469441 country
- The SHIELD Whole Lung Lavage StudyStatus unknownNCT054021761 country
- Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated SilicosisStatus unknownNCT05118256Phase 21 country
- The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment TrialStatus unknownNCT04161014Phase 21 country
- Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis PreventionCompletedNCT02430259Phase 31 country
- Short Course Rifapentine and Isoniazid for the Preventive Treatment of Tuberculosis(SCRIPT-TB)Status unknownNCT03900858Not applicable1 country
- Comprehensive Risk Assessment of People With Silicosis: A Population-based StudyCompletedNCT027947011 country
- Specialized Center of Research in Occupational and Immunologic Lung DiseaseCompletedNCT00005280
- Safety of Stem Cells Intrabronchial Instillation for SilicosisCompletedNCT01239862Phase 11 country
- Oscillation Mechanics of the Respiratory System in Never-smoking Patients With SilicosisCompletedNCT017259711 country
- Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat SilicosisCompletedNCT01977131Phase 1/2
- Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone)Status unknownNCT013380641 country
- DNA-damage Pathways in Workers Exposed to Silica (Caesar Stone)Status unknownNCT013290031 country